Helicobacter pylori infection in children with celiac disease: Multi-center, cross-sectional study

Nevzat Aykut Bayrak1, Engin Tutar2, Burcu Volkan3

  • 1Department of Pediatric Gastroenterology, Hepatology and Nutrition, Diyarbakir Children's Hospital, Diyarbakir, Turkey.

Helicobacter
|April 3, 2020
PubMed

Insights

Helicobacter pylori (Hp) infection was significantly less common in children with celiac disease (CD) compared to controls. Further research is needed to understand the causal relationship between Hp infection and childhood celiac disease development.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Immunology

Background:

  • Celiac disease (CD) and Helicobacter pylori (Hp) infection have a suggested inverse association in children, but data are inconsistent.
  • This multi-center study investigates the relationship between Hp infection and CD in pediatric patients.

Purpose of the Study:

  • To evaluate the association between Helicobacter pylori infection and celiac disease in childhood.

Main Methods:

  • A cross-sectional study included children undergoing endoscopy between July 2016 and November 2017.
  • Exclusion criteria included prior Hp eradication, recent antibiotic/acid-suppressive therapy, and chronic diseases.
  • Hp infection was confirmed by histopathology and rapid urease test; CD patients were compared to controls.

Main Results:

  • Of 2484 eligible cases, 482 had CD and 2060 were controls.
  • Hp infection rates were significantly lower in the CD group (26.3%) compared to controls (50.1%), P < .01.
  • This difference was notable in children under 6 years old, with no correlation found between Hp infection and modified Marsh scores in CD patients.

Conclusions:

  • The study found a significantly lower frequency of Hp infection in children with CD compared to controls.
  • Hp infection is prevalent in the pediatric population studied.
  • Further systematic cohort studies are required to establish a causal link between Hp infection and the development of celiac disease.
Abstract

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
462
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
948
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
994
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
674
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.0K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.0K